| Morphine Sulphate 60 mg/ml Solution for Injection PA0073/020/008 |
Morphine sulfate |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Morsadex 50 mg/2 ml solution for injection/infusion PA2165/002/001 |
Dexketoprofen trometamol |
AS Kalceks |
Marketed |
| Motilium 1 mg/ml Oral Suspension PA23490/039/001 |
Domperidone |
JNTL Consumer Health I (Ireland) Limited |
Not marketed |
| Motilium 10mg Film-Coated Tablets PA23490/022/002 |
Domperidone |
JNTL Consumer Health I (Ireland) Limited |
Marketed |
| Motilium Fastmelts 10mg Orodispersible Tablets PA23490/022/001 |
Domperidone |
JNTL Consumer Health I (Ireland) Limited |
Marketed |
| Motilium Rx 10 mg Film-coated Tablets PA23490/039/002 |
Domperidone |
JNTL Consumer Health I (Ireland) Limited |
Marketed |
| Motusol Max 2 % w/w gel PA1986/093/002 |
Diclofenac Diethylamine |
Teva B.V. |
Marketed |
| Motusol Rx 1 % w/w gel PA1986/093/001 |
Diclofenac Diethylamine |
Teva B.V. |
Not marketed |
| Mounjaro 10 mg solution for injection in pre-filled pen EU/1/22/1685/010-012 |
Tirzepatide |
Eli Lilly Nederland B.V. |
— |
| Mounjaro 10 mg/dose KwikPen solution for injection in pre-filled pen EU/1/22/1685/055-056 |
Tirzepatide |
Eli Lilly Nederland B.V. |
— |
| Mounjaro 12.5 mg solution for injection in pre-filled pen EU/1/22/1685/013-015 |
Tirzepatide |
Eli Lilly Nederland B.V. |
— |
| Mounjaro 12.5 mg/dose KwikPen solution for injection in pre-filled pen EU/1/22/1685/057-058 |
Tirzepatide |
Eli Lilly Nederland B.V. |
— |
| Mounjaro 15 mg solution for injection in pre-filled pen EU/1/22/1685/016-018 |
Tirzepatide |
Eli Lilly Nederland B.V. |
— |
| Mounjaro 15 mg/dose KwikPen solution for injection in pre-filled pen EU/1/22/1685/059-060 |
Tirzepatide |
Eli Lilly Nederland B.V. |
— |
| Mounjaro 2.5 mg solution for injection in pre-filled pen EU/1/22/1685/001-003 |
Tirzepatide |
Eli Lilly Nederland B.V. |
— |
| Mounjaro 2.5 mg/dose KwikPen solution for injection in pre-filled pen EU/1/22/1685/049-050 |
Tirzepatide |
Eli Lilly Nederland B.V. |
— |
| Mounjaro 5 mg solution for injection in pre-filled pen EU/1/22/1685/004-006 |
Tirzepatide |
Eli Lilly Nederland B.V. |
— |
| Mounjaro 5 mg/dose KwikPen solution for injection in pre-filled pen EU/1/22/1685/051-052 |
Tirzepatide |
Eli Lilly Nederland B.V. |
— |
| Mounjaro 7.5 mg solution for injection in pre-filled pen EU/1/22/1685/007-009 |
Tirzepatide |
Eli Lilly Nederland B.V. |
— |
| Mounjaro 7.5 mg/dose KwikPen solution for injection in pre-filled pen EU/1/22/1685/053-054 |
Tirzepatide |
Eli Lilly Nederland B.V. |
— |
| Moventig 12.5 mg film-coated tablets EU/1/14/962/001-003 |
Naloxegol oxalate |
Grünenthal GmbH |
— |
| Moventig 25 mg film-coated tablets EU/1/14/962/004-007 |
Naloxegol oxalate |
Grünenthal GmbH |
— |
| Movicol Paediatric Chocolate Flavour 6.9 g sachet powder for oral solution PA23265/001/002 |
Macrogol 3350, Sodium bicarbonate, Sodium chloride, Potassium chloride |
Norgine Healthcare B.V. |
Not marketed |
| Movicol 13.8 g sachet powder for oral solution PA23265/001/005 |
Macrogol 3350, Sodium bicarbonate, Sodium chloride, Potassium chloride |
Norgine Healthcare B.V. |
Marketed |
| Movicol 13.8g sachet, powder for oral solution PPA1925/002/001 |
Macrogol 3350, Sodium bicarbonate, Sodium chloride, Potassium chloride |
Novalus Healthcare Limited |
— |
| Movicol Chocolate 13.9 g sachet powder for oral solution PA23265/001/001 |
Macrogol 3350, Sodium chloride, Potassium chloride, Sodium hydrogen carbonate |
Norgine Healthcare B.V. |
Not marketed |
| Movicol Liquid Orange Flavour, Concentrate for Oral Solution PA23265/002/001 |
Macrogol 3350, Sodium chloride, Sodium hydrogen carbonate, Potassium chloride |
Norgine Healthcare B.V. |
Marketed |
| Movicol Paediatric Plain 6.9 g sachet powder for oral solution PA23265/001/003 |
Macrogol 3350, Sodium bicarbonate, Sodium chloride, Potassium chloride |
Norgine Healthcare B.V. |
Marketed |
| Movicol Plain 13.7 g sachet powder for oral solution PA23265/001/004 |
Macrogol 3350, Sodium bicarbonate, Sodium chloride, Potassium chloride |
Norgine Healthcare B.V. |
Not marketed |
| Movicol Ready to Take 13.9 g/25 ml oral solution in sachet PA23265/002/002 |
Macrogol 3350, Sodium chloride, Sodium hydrogen carbonate, Potassium chloride |
Norgine Healthcare B.V. |
Not marketed |
| Moviprep Orange, powder for oral solution PA1336/001/002 |
Macrogol 3350, Sodium sulfate anhydrous, Sodium chloride, Potassium chloride, Ascorbic acid |
Norgine B.V. |
Not marketed |
| Moviprep, powder for oral solution PA1336/001/001 |
Macrogol 3350, Sodium sulfate anhydrous, Sodium chloride, Potassium chloride, Ascorbic acid |
Norgine B.V. |
Marketed |
| Moviprep, powder for oral solution PPA1463/232/001 |
Macrogol 3350, Sodium sulfate anhydrous, Sodium chloride, Potassium chloride, Ascorbic acid |
IMED Healthcare Ltd., |
— |
| MOVIPREP, powder for oral solution PPA0465/428/001 |
Sodium ascorbate, Ascorbic acid, Potassium chloride, Sodium chloride, Sodium sulphate anhydrous |
PCO Manufacturing Ltd. |
— |
| Movymia 20 micrograms/80 microliters solution for injection EU/1/16/1161/001-002 |
Teriparatide |
Stada Arzneimittel AG |
— |
| Moxifloxacin 400 mg/250 ml Solution for Infusion, FreeFlex bags PA2059/013/002 |
Moxifloxacin |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Moxifloxacin 400 mg/250 ml Solution for Infusion, KabiPac bottles PA2059/013/001 |
Moxifloxacin |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Mozobil 20 mg/ml Solution for injection EU/1/09/537/001 |
Plerixafor |
Genzyme Europe B.V. |
— |
| mRESVIA EU/1/24/1849/001-002 |
Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation |
Moderna Biotech Spain S.L. |
— |
| MST Continus 10 mg Prolonged-release tablets PA1688/004/002 |
Morphine sulfate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| MST Continus 100mg Prolonged-release tablets PA1688/004/006 |
Morphine sulfate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| MST Continus 15 mg Prolonged-release tablets PA1688/004/003 |
Morphine sulfate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| MST Continus 30 mg Prolonged-release tablets PA1688/004/004 |
Morphine sulfate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| MST Continus 5 mg prolonged-release tablets PA1688/004/001 |
Morphine sulfate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Mubucho 111 mg film-coated tablets PA1701/003/006 |
Dasatinib |
Zentiva k.s. |
Not marketed |
| Mubucho 16 mg film-coated tablets PA1701/003/001 |
Dasatinib |
Zentiva k.s. |
Marketed |
| Mubucho 40 mg film-coated tablets PA1701/003/002 |
Dasatinib |
Zentiva k.s. |
Marketed |
| Mubucho 55 mg film-coated tablets PA1701/003/003 |
Dasatinib |
Zentiva k.s. |
Marketed |
| Mubucho 63 mg film-coated tablets PA1701/003/004 |
Dasatinib |
Zentiva k.s. |
Not marketed |
| Mubucho 79 mg film-coated tablets PA1701/003/005 |
Dasatinib |
Zentiva k.s. |
Marketed |